ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Synvista Therapeutics Inc (EM)

Synvista Therapeutics Inc (EM) (SYNI)

0.000001
0.00
(0.00%)
終了 7月9日 5:00AM

Synvista Therapeutics Inc (EM) (SYNI) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.000001
( - )
買値
0.00
売値
0.00
出来高
-
平均取引量 (3 か月)
US$ 260
財務取引量
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.000001
時価総額
企業価値
-
前日終値
0.000001
始値
-
時刻
最終取引時間
VWAP
-
歳入
54.73k
純利益
-10.96M
発行済株式数
2,586,326
浮動株比率 (%)
-
機関投資家保有比率 (%)
-
配当利回り
PER
-
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-7.66
ベータ
30.28

Synvista Therapeutics Inc (EM) について

Synvista Therapeutics, Inc., a product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease. The company’s products include ALT-2074, a glutathione peroxidase mimetic in Phase II clinic... Synvista Therapeutics, Inc., a product-based biopharmaceutical company, develops diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease. The company’s products include ALT-2074, a glutathione peroxidase mimetic in Phase II clinical trials for the treatment of diabetic patients with Hp2-2; and Alagebrium chloride or alagebrium, an Advanced Glycation End-product Crosslink Breaker in Phase II clinical trials for the treatment of diastolic heart failure and diabetic nephropathy. It is also developing a diagnostic test to identify and treat patients with diabetes who are in risk of cardiovascular disease. The company, formerly known as Alteon, Inc., was founded in 1986 and is headquartered in Montvale, New Jersey. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
本社
Montvale, United States
設立
1986
Synvista Therapeutics Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker SYNI. The last closing price for Synvista Therapeutics (EM) was US$0. Over the last year, Synvista Therapeutics (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.000001.

Synvista Therapeutics (EM) currently has 2,586,326 shares in issue. The market capitalisation of Synvista Therapeutics (EM) is US$2.59 . Synvista Therapeutics (EM) has a price to earnings ratio (PE ratio) of 0.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
12001.0E-61.0E-61.0E-600CS
26001.0E-61.0E-61.0E-600CS
52001.0E-61.0E-61.0E-61381.0E-6CS
156-9.9E-5-990.00010.00011.0E-63483.285E-5CS
260001.0E-60.00021.0E-63663.341E-5CS

SYNI - Frequently Asked Questions (FAQ)

What is the current Synvista Therapeutics Inc (EM) share price?
The current share price of Synvista Therapeutics Inc (EM) is US$ 0.000001
How many Synvista Therapeutics Inc (EM) shares are in issue?
Synvista Therapeutics Inc (EM) has 2,586,326 shares in issue
What is the market cap of Synvista Therapeutics Inc (EM)?
The market capitalisation of Synvista Therapeutics Inc (EM) is USD 2.59
What is the 1 year trading range for Synvista Therapeutics Inc (EM) share price?
Synvista Therapeutics Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.000001 during the past year
What is the cash to sales ratio of Synvista Therapeutics Inc (EM)?
The cash to sales ratio of Synvista Therapeutics Inc (EM) is 0
What is the registered address of Synvista Therapeutics Inc (EM)?
The registered address for Synvista Therapeutics Inc (EM) is 221 West Grand Avenue, Montvale, New Jersey, 07645
Which industry sector does Synvista Therapeutics Inc (EM) operate in?
Synvista Therapeutics Inc (EM) operates in the Pharmaceuticals sector

SYNI 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

SYNI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock